Preventing CMV in Stem Cell Transplant Patients

Review the latest expert guidance in this comprehensive program on the prevention and management of cytomegalovirus in hematopoietic cell transplant recipients which features a module with expert answers to frequently asked questions and an interactive case challenge.

Share

Supporters

Supported by an educational grant from

Merck & Co., Inc.